Aventura Private Wealth LLC Acquires New Stake in Stryker Corporation $SYK

Aventura Private Wealth LLC acquired a new position in Stryker Corporation (NYSE:SYK) during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor acquired 2,372 shares of the medical technology company’s stock, valued at approximately $834,000.

Several other institutional investors and hedge funds also recently bought and sold shares of SYK. Armstrong Advisory Group Inc. lifted its holdings in Stryker by 12.3% during the third quarter. Armstrong Advisory Group Inc. now owns 247 shares of the medical technology company’s stock valued at $91,000 after purchasing an additional 27 shares in the last quarter. Venturi Wealth Management LLC grew its position in shares of Stryker by 1.4% during the third quarter. Venturi Wealth Management LLC now owns 1,904 shares of the medical technology company’s stock valued at $704,000 after purchasing an additional 27 shares in the last quarter. Patriot Financial Group Insurance Agency LLC increased its stake in Stryker by 3.9% in the 3rd quarter. Patriot Financial Group Insurance Agency LLC now owns 745 shares of the medical technology company’s stock worth $275,000 after acquiring an additional 28 shares during the last quarter. Wolff Wiese Magana LLC grew its holdings in shares of Stryker by 2.3% in the third quarter. Wolff Wiese Magana LLC now owns 1,271 shares of the medical technology company’s stock valued at $470,000 after purchasing an additional 28 shares in the last quarter. Finally, Enterprise Financial Services Corp increased its position in Stryker by 4.3% in the second quarter. Enterprise Financial Services Corp now owns 705 shares of the medical technology company’s stock worth $279,000 after purchasing an additional 29 shares during the last quarter. 77.09% of the stock is currently owned by hedge funds and other institutional investors.

Insider Transactions at Stryker

In other news, Director Ronda E. Stryker sold 250,000 shares of the company’s stock in a transaction dated Wednesday, February 4th. The shares were sold at an average price of $362.92, for a total transaction of $90,730,000.00. Following the completion of the transaction, the director owned 2,457,331 shares of the company’s stock, valued at $891,814,566.52. This represents a 9.23% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Insiders own 5.90% of the company’s stock.

Stryker Stock Performance

Shares of SYK opened at $335.96 on Friday. Stryker Corporation has a 1 year low of $328.23 and a 1 year high of $404.87. The company’s 50 day simple moving average is $363.25 and its 200 day simple moving average is $366.04. The company has a market capitalization of $128.57 billion, a price-to-earnings ratio of 39.99, a PEG ratio of 1.99 and a beta of 0.85. The company has a debt-to-equity ratio of 0.66, a quick ratio of 1.21 and a current ratio of 1.89.

Stryker (NYSE:SYK) last issued its quarterly earnings results on Thursday, January 29th. The medical technology company reported $4.47 earnings per share for the quarter, beating the consensus estimate of $4.40 by $0.07. Stryker had a return on equity of 24.41% and a net margin of 12.92%.The company had revenue of $7.17 billion during the quarter, compared to the consensus estimate of $7.12 billion. During the same period in the previous year, the firm posted $4.01 EPS. Stryker’s revenue was up 11.4% on a year-over-year basis. On average, sell-side analysts predict that Stryker Corporation will post 13.47 EPS for the current year.

Stryker Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Thursday, April 30th. Investors of record on Tuesday, March 31st will be given a dividend of $0.88 per share. The ex-dividend date is Tuesday, March 31st. This represents a $3.52 annualized dividend and a yield of 1.0%. Stryker’s dividend payout ratio is 41.90%.

Wall Street Analyst Weigh In

Several analysts have recently issued reports on SYK shares. Citizens Jmp upgraded shares of Stryker from a “market perform” rating to an “outperform” rating and set a $440.00 target price on the stock in a research report on Friday, December 19th. Needham & Company LLC boosted their target price on shares of Stryker from $448.00 to $454.00 and gave the company a “buy” rating in a research note on Friday, January 30th. Raymond James Financial raised Stryker from a “market perform” rating to an “outperform” rating and set a $418.00 price objective on the stock in a research note on Tuesday, January 6th. Barclays reiterated an “overweight” rating and set a $469.00 target price on shares of Stryker in a report on Monday, February 2nd. Finally, The Goldman Sachs Group set a $399.00 price target on Stryker in a report on Friday, January 9th. Fourteen equities research analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $427.50.

About Stryker

Stryker Corporation is a global medical technology company that designs, manufactures and markets a broad range of products and services for use in hospitals, surgeons’ offices and other healthcare facilities. Its primary business activities span orthopedics (including joint replacement implants, trauma and extremities products), surgical equipment and operating room technologies (such as visualization, navigation and powered instruments), neurotechnology and spine solutions, and patient-handling and emergency medical equipment.